Wolfgang Miesbach: New Research Reveals Clonogenic Hepatocytes as the Key Drivers of Liver Growth and Gene Therapy Success
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“Only 15-20% of newborn hepatocytes generate 90% of adult liver tissue. New research from San Raffaele Telethon Institute characterizes hepatocyte heterogeneity and reveals that ‘clonogenic hepatocytes‘ – a small subset of liver cells in newborn mice – are responsible for most adult liver growth:
- Gene editing by HDR preferentially targets these clonogenic cells, expanding edited liver areas during growth
- Lentiviral vectors show age-dependent efficiency – higher in newborns, lower in adults (reversible with proteasome inhibition)
- Peri-central hepatocyte identity develops after weaning
- Clonogenic hepatocytes co-localize with hematopoietic progenitor cells in specialized tissue niches research
Gene Therapy Impact:
This discovery transforms pediatric gene therapy timing and targeting strategies. Understanding when and which hepatocytes to target could unlock more effective treatments for inherited liver diseases
The team used cutting-edge single-cell/spatial transcriptomics, clonal tracing, and mathematical modeling to map hepatocyte proliferation and maturation after birth
Congratulations to Alessio Cantore, Michela Milani, Francesco Starinieri, Matteo Iannacone, Renato Ostuni, Giulia Bortolussi, Ivan Merelli, Stefano Beretta, Marco Monti!”
Title: Spatiotemporal liver dynamics shape hepatocellular heterogeneity and impact in vivo gene engineering
Authors: Michela Milani, Francesco Starinieri, Stefano Beretta, Marco Monti, Cesare Canepari, Francesca Marabotti, Samuel Zambrano, Davide Mazza, Anna Fabiano, Chiara Simoni, Eugenia Cammarota, Monica Volpin, Giulia Bortolussi, Fabio Russo, Mauro Biffi, Marco Genua, Sara Degl’Innocenti, Francesca Sanvito, Renato Ostuni, Andrés F. Muro, Eugenio Montini, Federica Moalli, Matteo Iannacone, Ivan Merelli, Alessio Cantore

Read the full article here.
More recent insights on Hemostasis Today.
-
Nov 14, 2025, 11:58Marilena Vrana: Can Public-only Blood Collection Systems Meet the Growing Patient Need for PDMs?
-
Nov 14, 2025, 11:48Cedric Hermans Shares the 1st Illustrated Review Dedicated to Hemophilia B
-
Nov 14, 2025, 10:28Valance Washington: Proud to Share Our Lab’s Latest Publication in Platelets Journal
-
Nov 14, 2025, 10:18Sripal Bangalore and Ajay Kirtane on TUXEDO-2 Comparison Focusing on Diabetic Patients
-
Nov 14, 2025, 10:11Ashley Lawrenson on Her Coagulation Journey Using Automation With the HemoCell and HemoHub
-
Nov 14, 2025, 10:05Kingsley Wheaton: A Year Ago, Omni Was an Idea – Today, It’s a Movement!
-
Nov 14, 2025, 09:58Rucha Patil Takes The National DHR-ICMR Gold Award for Best Technology
-
Nov 14, 2025, 09:48Caitlin Raymond on ”The Plasma Chasers”
-
Nov 14, 2025, 09:42Erin VanDyke on Why They Do In-person Site Visits for NBCA Centers of Excellence Designation!
